Work

Access in all areas? A round up of developments in market access and health technology assessment: part 7

Year: 2025

Type: article

Abstract: In this update, we discuss the implementation progress of the Medicare Drug Price Negotiation Program, with particular focus on the second round of negotiations for 15 additional Part D drugs; explore the role of health technology assessment in US commercial health plan decision-making; and examine significant changes to pharmaceutical pricing systems in Germany, where international reference pricing has been eliminated as part of the Medical Research Act.

Source: Journal of Comparative Effectiveness Research

DOI: 10.57264/cer-2025-0043

Authors: Sreeram V Ramagopalan, Annie Jullien Pannelay

Institution: King's College London

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4409407513

FWCI: 3.89

Cites: 5

Cited by: 4

Related to: 10